Lv1
80 积分 2023-02-01 加入
Development of RMC-6236, a potent and orally bioavailable RAS(ON) multi-selective tri-complex inhibitor for the treatment of RAS-addicted cancers by targeting multiple RAS variants
3天前
已关闭
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
6天前
已完结
Studying Intermolecular Interactions in an Antibody-Drug Conjugate Through Chemical Screening and Computational Modeling
2个月前
已完结
Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment
2个月前
已关闭
Camptothecin Derivatives Antitumor Database
2个月前
已关闭
FDA approves 100th monoclonal antibody product
3个月前
已完结
CDR grafting and site-directed mutagenesis approach for the generation and affinity maturation of Anti-CD20 nanobody
3个月前
已完结
Recent Advances in Peptide Linkers for Antibody-Drug Conjugates
3个月前
已完结
Computationally designed antibody–drug conjugates self-assembled via affinity ligands
3个月前
已完结
Recent Advances in Peptide Linkers for Antibody-Drug Conjugates
3个月前
已完结
皖公网安备34019202002308
